Diethylstilboestrol (DES) - safety alerts & advisory statements

• Screening guidelines for women exposed in utero to diethylstilboestrol (DES)
  <http://www.tga.gov.au/alerts/medicines/des.htm>
  23 April 2008
• Medicine regulator provides further advice for women exposed to diethylstilboestrol (DES)
  <http://www.tga.gov.au/media/2008/080423des.htm>
  Media statement, 23 April 2008
• Doctors urged to keep check on daughters of women who used pregnancy drug three decades ago
  <http://www.tga.gov.au/media/2004/040609_des.htm>
  Media statement, 4 June 2004 (includes November 2007 update)

Other information on DES

• Section 9.4 of the NHMRC's Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities provides guidance for the management of women exposed in utero to diethylstilboestrol
  <http://www.nhmrc.gov.au/publications/synopses/wh39syn.htm>
• The website of the US Centers for Disease Control has a very extensive set of materials about DES for health professionals and consumers.
  <http://www.cdc.gov./dex>